STAAR Surgical (STAA) Tops Q1 EPS by 8c, Beats on Revenues

STAAR Surgical (NASDAQ: STAA) reported Q1 EPS of $0.04, $0.08 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $27.09 million versus the consensus estimate of $23.05 million.

First Quarter 2018 Overview

• Net Sales of $27.1 Million Up 33% from the Prior Year Quarter
• ICL Sales Up 39% and Units Up 41% from the Prior Year Quarter
• Other Sales Up 17% from the Prior Year Quarter
• Gross Margin at 71.7% of Sales from 71.6% of Sales in the Prior Year Quarter
• Earnings per Share of $0.01 from a Loss per Share of ($0.05) in the Prior Year Quarter
• Cash, Cash Equivalents and Restricted Cash Up $2.3 Million Sequentially to $20.9 Million at Quarter End.

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.

You May Also Be Interested In

• Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
• LATAM Airlines (LTM) Misses Q3 EPS by 135c
• Limbach Holdings (LMB) Tops Q3 EPS by 16c, Beats on Revenue; Offers FY26 Revenue Guidance